Ligand Pharmaceuticals (LGND) EV to CFO (2012 - 2026)
Ligand Pharmaceuticals' EV to CFO was 37.50 in Q2 2026, up 5.8% from 35.44 a year earlier and up 43.8% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) EV to CFO (2012 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ligand Pharmaceuticals' EV to CFO was 20.96 through Jun 30, 2026, down 9.1% year-over-year; for FY2025, it came in at 60.88, up 229.9% from FY2024.
- In earlier years, EV to CFO was 18.46 in FY2024 (-15.6%), 21.86 in FY2023 (+227.3%), 6.68 in FY2022 (-58.7%) and 16.18 in FY2021 (+50.6%).
- Quarterly EV to CFO has moved between 6.68 (Q4 2022) and 88.28 (Q3 2025) over five years.
- Compared with a year earlier, EV to CFO was higher in six of the last eight quarters, with growth averaging 86.7%.
- The best year-over-year quarter for EV to CFO over five years was Q3 2021 (growth of 530.8%); the worst was Q2 2022 (a decline of 70.3%).
- Per Business Quant data, LGND's EV to CFO in the three quarters before Q2 2026 was 26.07 (Q1 2026), 60.88 (Q4 2025) and 88.28 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ligand Pharmaceuticals | 6.22 Bn | 2.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.50 |
| Mar 31, 2026 | 26.07 |
| Dec 31, 2025 | 60.88 |
| Sep 30, 2025 | 88.28 |
| Jun 30, 2025 | 35.44 |
| Mar 31, 2025 | 34.38 |
| Dec 31, 2024 | 18.46 |
| Sep 30, 2024 | 21.63 |
| Jun 30, 2024 | 27.19 |
| Mar 31, 2024 | 29.09 |
| Dec 31, 2023 | 21.86 |
| Sep 30, 2023 | 8.98 |
| Jun 30, 2023 | 9.57 |
| Mar 31, 2023 | 8.16 |
| Dec 31, 2022 | 6.68 |
| Sep 30, 2022 | 7.02 |
| Jun 30, 2022 | 7.10 |
| Mar 31, 2022 | 8.16 |
| Dec 31, 2021 | 16.18 |
| Sep 30, 2021 | 21.84 |
API Access
Ligand Pharmaceuticals EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();